Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria

Journal of Neural Transmission

Volumn 120, Issue 11, 2013, Pages 1539-1551

  Naoi, Makoto ^a,b   Maruyama, Wakako ^c   Yi, Hong ^a  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Apoptosis; Mitochondrial permeabilization; Monoamine oxidase; Neuroprotection; PK11195; Rasagiline

Indexed keywords

CASPASE 3; CYTOCHROME C; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RASAGILINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME ASSAY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUROPROTECTION; OUTER MEMBRANE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; INDANS; ISOQUINOLINES; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 84887222382     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1033-x     Document Type: Article

References (55)

1. Akao Y, Maruyama W, Shimizu S et al (2002) Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)- aminoindan. J Neurochem 82:913-923
2. Anholt RRH, Pedersen L, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor. J Biol Chem 261:576-583
3. Binda C, Hubalek F, Li M, Herzig Y, Sterling J, Edmondson DE, Mattevi A (2005) Binding of rasagiline-related inhibitors to human monoamine oxidases; a kinetic and crystallographic analysis. J Med Chem 48:8148-8154
4. Blandini F, Armentero MT, Fancellu R, Blaugrund E, Nappi G (2004) Neuroprotective effect of rasagiline in a rodent model of Parkinson' disease. Exp Neurol 187:455-459
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 72:248-254
6. De Marchi U, Pietrangeli P, Marcocci L, Mondovi B, Toninello A (2003) l-Deprenyl as an inhibitor of menadione-induced permeability transition in liver mitochondria. Biochem Pharmacol 66:1749-1754
7. Doran E, Halestrap AP (2000) Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites. Biochem J 348:343-350
8. Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, ReFacy HE, Carlson EC (2006) Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases. Curr Drug Targets 7:1513-1529
9. Eckert A, Steiner B, Marques C, Leutz S, Roming H, Hass C, Muller WE (2001) Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. N Neurosci Res 64:183-192
10. Enari M, Hase A, Nagata S (1995) Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J 14:5201-5208
11. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G (2006) Mechanism of cytochrome c release from mitochondria. Cell Death Differ 13:1423-1433
12. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisingwe G, Weizman A (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629-650
13. Gonzalez-Polo R, Carvalho G, Braun T et al (2005) PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepine receptor. Oncogene 24:7503-7513
14. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626-629
15. Grimm S, Brdiczka D (2007) The permeability transition pore in cell death. Apoptosis 12:841-855
16. Hong-Rong XIE, Lin-Sen HU, Guo-Yi LI (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med 123:1086-1092
17. Hubalek F, Binda C, Ki M, Herzig Y, Sterling J, Youdim MBH, Mattevi A, Edmondson DE (2004) Inactivation of purified human recombinant monoamine oxidase A and B by rasagiline and its analogues. J Med Chem 47:1760-1768
18. Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2012) Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. J Neural Transm 119:405-414
19. Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2013) Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. J Neural Transm 120:435-444
20. Kinnally KW, Antinsson B (2007) A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 12:857-868
21. Kowaltowski AJ, Fiskum G (2005) Redox Mechanisms of cytoprotection by Bcl-2. Antioxid Redox Signal 7:508-514
22. Kraml M (1965) A rapid microfluorometric determination of monoamine oxidase. Biochem Pharmacol 14:1684-1686
23. Kupsch A, Sautter J, Götz ME et al (2001) Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP1012) with selegiline. J Neural Transm 108:985-1009
24. Lai CT, Yu PH (1997) R(-)-deprenyl potentiates dopamine-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Appl Pharmacol 142:186-191
25. Lambert AJ, Brand MD (2004) Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoreductase (complex I). J Biol Chem 279:39414-39420
26. Lamensdorf I, Youdim MBH, Finberg JPM (1996) Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum. J Neurochem 67:1532-1539
27. Lee CS, Lee CS, Ko HH, Song JH, Han ES (2002) Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria. Neurochem Res 27:215-224
28. Maaser K, Sutter AP, Scherübl H (2005) Mechanisms of mitochondrial apoptosis induced by benzodiazepine receptor ligands in human colorectal cancer cells. Biochem Biophys Res Commun 332:646-652
29. Mangan PS, Colombini M (1987) Ultrasteep voltage dependence in a membrane channel. Proc Natl Acad Sci USA 84:4896-4900
30. Maruyama W, Naoi M (2013) "70th Birthday Professor Riederer" Induction of glial cell-line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy? J Neural Transm 120:83-89
31. Maruyama W, Strolin Benedett M, Takahasi T, Naoi M (1997) A neurotoxin, N-methyl(R)salsolinol induces apoptosis in human differentiated dopaminergic neuroblastoma SH-SY5Y cells. Neurosci Lett 237:147-150
32. Maruyama W, Akao Y, Youdim M, Naoi M (2000) Neurotoxin induced apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, Rasagiline and TV1022. J Neural Transm 60(Suppl):171-186
33. Maruyama W, Akao Y, Youdim MBH, Davis BA, Naoi M (2001) Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehydes-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem 78:727-735
34. Maruyama W, Takahashi T, Youdim M, Naoi M (2002) The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm 109:467-481
35. Maruyama W, Nitta A, Shamoto-Nagai M et al (2004) N-propargyl-1(R)- aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-κB transcription factor. Neurochem Int 44:393-400
36. Mazzulli JR, Mishizen AJ, Giasson BI et al (2006) Cytosolic catechols inhibit a-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci 26:1068-10078
37. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G (1996) Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA 93:9893-9898
38. Naoi M, Maruyama W (2010) Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders. Curr Pharm Design 16:2799-2817
39. Naoi M, Maruyama W, Akao Y, Zhang J, Parvez H (2000) Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons. Toxicology 153:123-141
40. Naoi M, Maruyama W, Inaba-Hasegawa K, Akao Y (2011) Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection. Int Rev Neurobiol 100:85-106
41. Naoi M, Maruyama W, Inaba-Hasegawa K (2013) Revelation in neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. Expert Rev Neurother (in press)
42. Olanow CW, Rascol O, Hauser R et al (2009) A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Eng J Med 361:1268-1278
43. Olson JM, McNeed W, Young AB, Mancini WR (1992) Localization of peripheral-type benzodiazepine binding site to mitochondria of human glioma cells. J Neurosci 13:35-42
44. Riederer P, Laux G (2011) MAO-inhibitors in Parkinson's disease. Exp Neurobiol 20:1-17
45. Schwarz M, Andrade-Navarro M, Gross A (2007) Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? Apoptosis 12:869-876
46. Seleikyte J, Petronilli V, Zulian A et al (2011) Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J Biol Chem 28:1046-1053
47. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487
48. Speiser Z, Mayk A, Litinetsky L, Fine T, Nyska A, Blaugrund E, Cohen S (2007) Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat. J Neural Transm 114:595-605
49. Tatton WG, Chalmers-Redman RME, Ju WJH et al (2002) Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301:753-764
50. Tsujimoto Y, Shimizu S (2000) VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 7:1174-1181
51. Veeman L, Alten J, Linnemannstöns K et al (2010) Potential involvement of FF1-ATP(syth)ase and reactive oxygen species in apoptosis induction in the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines. Apoptosis 15:753-768
52. Weireb O, Bar-Am O, Amit T, Chillag-Talmor O, Youdim MBH (2004) Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members. FASEB J 18:1471-1473
53. Wicker U, Bucheler K, Gellerich FN, Wagner M, Kapischke M, Brdiczka D (1993) Effect of macromolecules on the structure of the mitochondrial intermembrane space and the regulation of hexokinase. Biochim Biophys Acta 1142:228-239
54. Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M (2006) Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. J Neurochem 96:541-549
55. Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295-309